Answers are grounded in this paper and cite their sources.
Salivary duct carcinoma (SDC) is a rare but aggressive malignancy of the salivary glands, characterized by distinctive morphologic features and significant immunophenotypic heterogeneity. Accurate diagnosis can be challenging, particularly on cytology, due to overlap with other high-grade salivary gland carcinomas. We present a case series of five patients with SDC, highlighting the clinicocytologic, histopathologic, and immunohistochemical spectrum of this entity. The cases included primary tumors of the parotid and submandibular glands, tumors with regional lymph node metastasis, and carcinomas arising in pleomorphic adenoma. Cytologic evaluation revealed high cellularity, apocrine-type cells, marked nuclear pleomorphism, and frequent necrosis. Histopathology demonstrated high-grade architecture with comedo-type necrosis and adverse features such as perineural or lymphovascular invasion. Immunohistochemical analysis showed variable androgen receptor (AR) and human epidermal growth factor receptor-2 (HER2) expression, including AR-positive, HER2-positive, dual-positive, and AR-negative/HER2-positive phenotypes. This series underscores the importance of integrated morphologic assessment and routine dual AR and HER2 testing for accurate classification of SDC.
No takes yet. Share an insight, caveat, or question.
Baba et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: